Development of a database for investigating characteristics and quality of published clinical trials in chronic obstructive pulmonary disease: design, implementation, and application
6 affiliations
- 1Lung Disease Diagnosis and Treatment Center, National Medical Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450003 China
- 2Henan International Joint Laboratory of Evidence-Based Evaluation for Respiratory Diseases, Henan Province Clinical Research Center for Respiratory Diseases, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450003 China
- 3Global Health Trials Unit, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, L3 5QA UK
- 4School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an Jiaotong University, Xi’an, 710061 China
- 5Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Construction By Henan Province & Education Ministry of P.R. China/Henan Key Laboratory of Chinese Medicine for Respiratory Diseases, Henan University of Chinese Medicine, Zhengzhou, 450046 China
- 6Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou, 450046 China
Abstract
Background: Given the increasing long-term burden of chronic obstructive pulmonary disease (COPD), scientifically rigorous, efficient, and sustainable disease management has become a critical priority. However, the exponential proliferation of publications and the increasing granularity of research topics have amplified the difficulty of retrieving, integrating, and utilizing clinical evidence. Establishing a systematically curated, disease-specific clinical trial database can therefore provide a robust data foundation for diverse secondary research.
Methods: Using a combined strategy of individual-level literature searching and meta-epidemiological approaches, we systematically searched for primary clinical trial reports published before June 30, 2023. The literature data were sourced from PubMed, Cochrane Library, China National Knowledge Infrastructure (CNKI), VIP Database, Wanfang Database, and China Biology Medicine Database (CBM). Trial data were extracted using the CONSORT reporting standards, and the risk of bias in clinical trials was assessed using the ROB 2.0.
Results: In the search results, we identified 36,127 English RCTs and 142,670 Chinese RCTs, along with 4019 English meta-analyses and 3219 Chinese meta-analyses. Screening of the English-language literature was completed, and upon merging the two sets of search results, a duplication rate of 61.6% was found, resulting in the inclusion of 2261 primary trial reports. The included literature primarily focused on drug treatment [1087 (48.1%)] and pulmonary rehabilitation studies [607 (26.8%)]. Within drug treatment research, inhaled western medications garnered the most attention [684 (30.3%)], followed by oral western medications [299 (13.2%)].
Conclusion: This study preliminarily established a structured, manually curated database comprising 2261 English-language COPD clinical trials. Currently, the repository provides a preliminary stratification of these trials and illustrates the superior comprehensiveness of a dual-track retrieval strategy over a single search approach. Moving forward, the database will transition into an open-access research platform and be continuously updated to ensure its comprehensiveness and timeliness.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13063-026-09923-w.
Related
- Real-World Implementation and Clinical Outcomes of Mavacamten in an Underserved Urban Cohort With Obstructive Hypertrophic Cardiomyopathy
- Development and validation of an interpretable machine learning model for early prediction of mortality in ICU patients with chronic obstructive pulmonary disease and heart failure
- Association between the triglyceride-glucose-waist circumference index and obstructive sleep apnoea: a hospital-based case-control study in China and the development of machine learning models.
- Implementation of a WatchPAT‐Based Diagnostic Pathway for Obstructive Sleep Apnea in a Tertiary Hypertension Center: A Feasibility Study
- Risk factor analysis and development of a risk prediction model for facial pressure injury associated with noninvasive positive pressure ventilation in patients with chronic obstructive pulmonary disease based on symptom science theory
BibTeX
@article{zhang2026development,
title = {{Development of a database for investigating characteristics and quality of published clinical trials in chronic obstructive pulmonary disease: design, implementation, and application}},
author = {Yiyin Zhang and Yanfei Zhao and Peng Zhang and Shiyu Zhu and Tao Tian and Yanrong Zhang and Decao Li and Tao Chen and Jiansheng Li and Yang Xie},
journal = {Trials},
year = {2026},
month = jul,
doi = {10.1186/s13063-026-09923-w},
url = {https://doi.org/10.1186/s13063-026-09923-w},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Development of a database for investigating characteristics and quality of published clinical trials in chronic obstructive pulmonary disease: design, implementation, and application
AU - Yiyin Zhang
AU - Yanfei Zhao
AU - Peng Zhang
AU - Shiyu Zhu
AU - Tao Tian
AU - Yanrong Zhang
AU - Decao Li
AU - Tao Chen
AU - Jiansheng Li
AU - Yang Xie
PY - 2026
DA - 2026/07/27
JO - Trials
DO - 10.1186/s13063-026-09923-w
UR - https://doi.org/10.1186/s13063-026-09923-w
AB - Background: Given the increasing long-term burden of chronic obstructive pulmonary disease (COPD), scientifically rigorous, efficient, and sustainable disease management has become a critical priority. However, the exponential proliferation of publications and the increasing granularity of research topics have amplified the difficulty of retrieving, integrating, and utilizing clinical evidence. Establishing a systematically curated, disease-specific clinical trial database can therefore provide a robust data foundation for diverse secondary research. Methods: Using a combined strategy of individual-level literature searching and meta-epidemiological approaches, we systematically searched for primary clinical trial reports published before June 30, 2023. The literature data were sourced from PubMed, Cochrane Library, China National Knowledge Infrastructure (CNKI), VIP Database, Wanfang Database, and China Biology Medicine Database (CBM). Trial data were extracted using the CONSORT reporting standards, and the risk of bias in clinical trials was assessed using the ROB 2.0. Results: In the search results, we identified 36,127 English RCTs and 142,670 Chinese RCTs, along with 4019 English meta-analyses and 3219 Chinese meta-analyses. Screening of the English-language literature was completed, and upon merging the two sets of search results, a duplication rate of 61.6% was found, resulting in the inclusion of 2261 primary trial reports. The included literature primarily focused on drug treatment [1087 (48.1%)] and pulmonary rehabilitation studies [607 (26.8%)]. Within drug treatment research, inhaled western medications garnered the most attention [684 (30.3%)], followed by oral western medications [299 (13.2%)]. Conclusion: This study preliminarily established a structured, manually curated database comprising 2261 English-language COPD clinical trials. Currently, the repository provides a preliminary stratification of these trials and illustrates the superior comprehensiveness of a dual-track retrieval strategy over a single search approach. Moving forward, the database will transition into an open-access research platform and be continuously updated to ensure its comprehensiveness and timeliness. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13063-026-09923-w.
SN - 1745-6215
ER -